Search Login Register
Tretinoin
(Retinoic Acid)
Summary
Description:
An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE).
Also Known As:
Retinoic Acid; all-trans-Retinoic Acid; Retin-A; Vitamin A Acid; Vesanoid Show All >>
Networked: 7123
relevant articles (529 outcomes,
834 trials/studies)
for this Drug
Key Diseases for which Tretinoin is
Relevant
-
Acute Promyelocytic Leukemia
:
232 outcomes 93 studies in 1135 results
-
Acne Vulgaris
:
44 outcomes 66 studies in 302 results
-
Neoplasms (Cancer)
:
40 outcomes 94 studies in 853 results
-
Leukemia
:
36 outcomes 43 studies in 532 results
-
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
:
15 outcomes 19 studies in 146 results
Show All >>
Drugs Related to Tretinoin
-
arsenic trioxide (Trisenox)
-
Tretinoin (Retinoic Acid)
-
retinoic acid receptor alpha
-
Retinoids
-
Vitamin A (Retinol)
-
hydroquinone (Black and White)
-
Aligeron (AS 2)
-
promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein
-
adapalene (Differin)
-
Benzoyl Peroxide
Show All >>
Therapies Related to Tretinoin
-
Drug Therapy (Chemotherapy)
-
Microspheres (Microsphere)
-
Remission Induction
-
Aftercare (After-Treatment)
-
Chemoprevention
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2013 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.